Microcirculation and Tumor-Infiltrating Macrophages in Choroidal and Ciliary Body Melanoma and Corresponding Metastases

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 1, 2004, Pages 1-6

  Toivonen, Päivi ^a   Mäkitie, Teemu ^a   Kujala, Emma ^a   Kivelä, Tero ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; EPITOPE;

ADULT; ARTICLE; CANCER SURVIVAL; CELL TYPE; CHOROID MELANOMA; CILIARY BODY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MICROCIRCULATION; PRIORITY JOURNAL; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL MOVEMENT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MACROPHAGES; MALE; MELANOMA; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 0347988288     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0622     Document Type: Article

References (32)

1. Manschot WA, van Strik R. Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review. Int Ophthalmol. 1992;16:91-99.
2. Eskelin S, Pyrhönen S, Summanen P, Hahka-Kemppinen M, Kivelä T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology. 2000;107:1443-1449.
3. Jensen OA. Malignant melanomas of the uvea in Denmark 1943-1952: a clinical, histopathological, and prognostic study. Acta Ophthalmol Suppl. 1963;75:1-220.
4. Rajpal S, Moore R, Karakousis CP. Survival in metastatic uveal melanoma. Cancer. 1983;52:334-336.
5. Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991;98:383-389.
6. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Hoffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer. 1993;72:2219-2223.
7. Folberg R, Rummelt V, Parys-van Ginderdeuren R, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993;100:1389-1398.
8. McLean IW, Keefe KS, Burnier MN. Uveal melanoma: comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology. 1997;104:777-780.
9. Seregard S, Spångberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology. 1998;105:485-491.
10. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst. 1999;91:359-367.
11. Foss AJE, Alexander RA, Jefferies LW, Hungerford JL, Harris AL, Lightman S. Microvessel count predicts survival in uveal melanoma Cancer Res. 1996;56:2900-2903.
12. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 1999;40:2471-2480.
13. Chen X, Maniotis AJ, Majumdar D, Pe'er J, Folberg R. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci. 2002;43:2533-2539.
14. + cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42:1414-1421.
15. Clarijs R, Otte-Holler I, Ruiter DJ, de Waal RM. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci. 2002;43:912-918.
16. Salmon RJ, Levy C, Plancher C, et al. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol. 1998;24:127-130.
17. Eskelin S, Pyrhönen S, Hahka-Kemppinen M, Tuomaala S, Kivelä Kiveld T. A prognostic model and staging for metastatic uveal melanoma. Cancer. 2003;97:465-475.
18. Kivelä T, Suciu S, Hansson J, et al. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. Eur J Cancer. 2003;39:1115-1120.
19. Rummelt V, Mehaffey MG, Campbell RJ, et al. Microcirculation architecture of metastases from primary ciliary body and choroidal melanomas. Am J Ophthalmol. 1998;126:303-305.
20. Fuchs U, Kivelä T, Summanen P, Immonen I, Tarkkanen A. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma. Am J Pathol. 1992;141:169-181.
21. Burnier MJ, McLean IW, Gamel JW. Immunohistochemical evaluation of uveal melanocytic tumors: expression of HMB-45, S-100 protein, and neuron-specific enolase. Cancer. 1991;68:809-814.
22. Steuhl KP, Rohrbach JM, Knorr M, Thiel HJ. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors. Ophthalmology. 1993;100:208-215.
23. Ramani P, Bradley NJ, Fletcher CDM. QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathology. 1990;17:237-242.
24. Kivelä T. Immunohistochemical staining followed by bleaching of melanin: a practical method for ophthalmic pathology. Br J Biomed Sci. 1995;52:325-326.
25. Folberg R, Pe'er J, Gruman LM, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol. 1992;23:1298-1305.
26. Foss AJE, Alexander RA, Hungerford JL, Harris AL, Cree IA, Lightman S. Reassessment of the PAS patterns in uveal melanoma. Br J Ophthalmol. 1997;81:240-246.
27. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: John Wiley & Sons; 1981.
28. Schaling DF, Van der Pol JP, Schlingemann RO, Parys-van Ginderdeuren R, Ruiter DJ, Jager MJ. Vascular density and vascular patterns in the prognosis of choroidal melanoma. Schaling DF: Thesis: Radionuclides and Radiolabelled Antibodies in Choroidal Melanoma (Diagnosis and Therapy). Leiden, The Netherlands: University of Leiden; 1996:43-54.
29. Folberg R, Chen X, Boldt HC, et al. Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas. Ophthalmology. 2001;108:996-1001.
30. Clarijs R, Schalkwijk L, Ruiter DJ, de Waal RM. EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:1801-1806.
31. Dithmar S, Rusciano D, Grossniklaus HE. A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma. Melanoma Res. 2000;10:2-8.
32. Apte RS, Niederkorn JY, Mayhew E, Alizadeh H. Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases. Arch Ophthalmol. 2001;119:1805-1809.